Pomalyst 3 MG
Ended Awarded Last action
- Contract number
- 36C24526N0520
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,888
Award facts
- Contract value 100% obligated
- $10,887.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Memphis, TN 38141, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company was awarded a delivery order valued at $10,887.52 on April 16, 2026, for the supply of POMALYST 3 MG to Veterans Integrated Service Network 5 (VISN 5), with an ultimate completion date of April 23, 2026. This firm fixed-price delivery order is issued under Bristol-Myers Squibb's Federal Supply Schedule contract (ID: 36F79724D0101) for Pharmaceuticals and Drugs (FSS-61-IB) with the Department of Veterans Affairs, a master schedule vehicle with a substantial ceiling value of $12.28 billion extending through April 30, 2029. The contract carries no set-aside designation and reflects Bristol-Myers Squibb's status as a large pharmaceutical manufacturer supplying advanced oncology therapies to the VA healthcare system.
POMALYST is a specialty oncology pharmaceutical used in the treatment of hematologic malignancies, representing one of Bristol-Myers Squibb's core product offerings through its VA supply agreements. The delivery will be performed at the place of performance in Memphis, Tennessee, supporting the VA's mission to provide eligible veterans with access to current standard-of-care cancer treatments and specialized immunotherapy products. This delivery order exemplifies the sustained procurement activity across multiple Veterans Integrated Service Networks, with more than fifty documented orders issued to Bristol-Myers Squibb since 2022 to support the Veterans Health Administration's oncology and cell therapy treatment programs.
Quick answers
Who was awarded contract 36C24526N0520?
36C24526N0520 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 16, 2026.
How much is contract 36C24526N0520 worth?
The government has obligated $10,888 on 36C24526N0520.
Is contract 36C24526N0520 an order under another contract?
Yes. 36C24526N0520 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0520 competed?
The extent of competition for 36C24526N0520 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award